Back
Rohto Pharmaceutical Co., Ltd. 10K Form
Sell
31
RPHCF
Rohto Pharmaceutical Co., Ltd.
Last Price:
$15.20
Seasonality Move:
5.18%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RPHCF News And Ratings
See the #1 stock for the next 7 days that we like better than RPHCF
RPHCF Financial Statistics
Sales & Book Value
| Annual Sales: | $2B |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $8.12 |
| Price / Book: | 1.87 |
Profitability
| EPS (TTM): | 0.99270 |
|---|---|
| Net Income (TTM): | $232.4M |
| Gross Margin: | $1.1B |
| Return on Equity: | 12.35% |
| Return on Assets: | 8.14% |
Rohto Pharmaceutical Co., Ltd. Earnings Forecast
Key Rohto Pharmaceutical Co., Ltd. Financial Ratios
-
The Gross Profit Margin over the past 43 years for RPHCF is 54.91%.
-
The Selling, General & Administrative Expenses for RPHCF have been equal to 44.07% of Gross Profit Margin.
-
The Research & Development expenses have been 4.86% of Revenue.
-
The Interest Expense is 3.07% of Operating Income.
-
The Net Earning history of RPHCF is 10.03% of Total Revenues.
-
Per Share Earnings over the last 43 years have been positive in 24 years.
Rohto Pharmaceutical Co., Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Personal Care Products |
| Sector: | Consumer Staples |
| Current Symbol: | RPHCF |
| Website: | rohto.co.jp |
Debt
| Debt-to-Equity Ratio: | 0.18 |
|---|---|
| Current Ratio: | 2.03 |
| Quick Ratio: | 1.35 |
Price-to-Earnings
| Trailing P/E Ratio: | 17.11 |
|---|---|
| Forward P/E Ratio: | 0 |
RPHCF Technical Analysis vs Fundamental Analysis
Sell
31
Rohto Pharmaceutical Co., Ltd. (RPHCF)
is a Sell
Is Rohto Pharmaceutical Co., Ltd. a Buy or a Sell?
-
Rohto Pharmaceutical Co., Ltd. stock is rated a SellThe current Rohto Pharmaceutical Co., Ltd. [RPHCF] share price is $15.20. The Score for RPHCF is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.